RHK Stock Overview
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
RHÖN-KLINIKUM Aktiengesellschaft Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €12.90 |
| 52 Week High | €14.00 |
| 52 Week Low | €9.45 |
| Beta | -0.029 |
| 1 Month Change | 18.35% |
| 3 Month Change | 29.00% |
| 1 Year Change | 1.57% |
| 3 Year Change | -17.10% |
| 5 Year Change | -51.59% |
| Change since IPO | 399.18% |
Recent News & Updates
Recent updates
Shareholder Returns
| RHK | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 19.4% | -1.6% | 1.2% |
| 1Y | 1.6% | -3.9% | 2.0% |
Return vs Industry: RHK exceeded the German Healthcare industry which returned -3.9% over the past year.
Return vs Market: RHK matched the German Market which returned 2% over the past year.
Price Volatility
| RHK volatility | |
|---|---|
| RHK Average Weekly Movement | 10.6% |
| Healthcare Industry Average Movement | 6.2% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: RHK's share price has been volatile over the past 3 months.
Volatility Over Time: RHK's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1973 | 14,132 | Tobias Kaltenbach | www.rhoen-klinikum-ag.com |
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.
RHÖN-KLINIKUM Aktiengesellschaft Fundamentals Summary
| RHK fundamental statistics | |
|---|---|
| Market cap | €890.28m |
| Earnings (TTM) | €38.71m |
| Revenue (TTM) | €1.73b |
23.0x
P/E Ratio0.5x
P/S RatioIs RHK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RHK income statement (TTM) | |
|---|---|
| Revenue | €1.73b |
| Cost of Revenue | €1.53b |
| Gross Profit | €202.88m |
| Other Expenses | €164.16m |
| Earnings | €38.71m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 08, 2024
| Earnings per share (EPS) | 0.58 |
| Gross Margin | 11.69% |
| Net Profit Margin | 2.23% |
| Debt/Equity Ratio | 11.1% |
How did RHK perform over the long term?
See historical performance and comparison